Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)

NCT00864942 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Chronic Lymphocytic Leukemia
Non-Hodgkin's Lymphoma

Interventions

DRUG: bendamustine and lenalidomide
DRUG: BL-NHL
DRUG: BLR-CLL
DRUG: BLR-NHL

Sponsor

Georgetown University

Collaborators

[object Object]
[object Object]